Study of GS-6637 for the treatment of cocaine use disorders

Trial Profile

Study of GS-6637 for the treatment of cocaine use disorders

Planning
Phase of Trial: Phase II

Latest Information Update: 18 Feb 2017

At a glance

  • Drugs GS 6637 (Primary)
  • Indications Cocaine abuse
  • Focus Adverse reactions
  • Sponsors Amygdala Neurosciences
  • Most Recent Events

    • 18 Feb 2017 New trial record
    • 16 Feb 2017 According to a Amygdala Neurosciences media release, the company plans to initiates this study in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top